Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Meihao Medical Group Co., Ltd. ( (HK:1947) ) has provided an update.
Meihao Medical Group Co., Ltd. reported its annual financial results for the year ended December 31, 2024. The company experienced a slight revenue increase of 1.6% to RMB74.7 million. However, the financial results showed a significant deterioration in profitability, with a loss before tax of RMB30.1 million compared to RMB7.2 million in the previous year. The loss attributable to equity holders also worsened to RMB32.4 million from RMB13.6 million in 2023. Consequently, the board has decided not to recommend a final dividend for 2024, highlighting the challenging financial environment the company faces.
More about Meihao Medical Group Co., Ltd.
YTD Price Performance: -5.41%
Average Trading Volume: 222,500
Technical Sentiment Signal: Buy
Current Market Cap: HK$210.1M
See more insights into 1947 stock on TipRanks’ Stock Analysis page.